KARIN BEALS: Open Payments
NPI 1386981413 · OWASSO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 69 payments from 18 companies in 2025. Trend: 2023 $1,113 · 2024 $1,278 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $332 |
| PFIZER INC. | 18 | $295 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $116 |
| Astellas Pharma US Inc | 3 | $85 |
| Abbott Laboratories | 1 | $76 |
| ABBVIE INC. | 4 | $71 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $46 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: Ozempic, ELIQUIS, NURTEC ODT, CAPLYTA, Veozah, FREESTYLE LIBRE 3, Wegovy, GEMTESA.
Industry payments across OK — which companies pay providers there.
